Group One Trading, L.P. Evaxion Biotech A/S Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.48 - $1.33 $1,333 - $3,694	-2,778 Reduced 87.8%	386 $0
Q2 2023 Aug 09, 2023	SELL	$1.12 - $1.74 $2,972 - $4,617	-2,654 Reduced 45.62%	3,164 $4,000
Q1 2023 May 12, 2023	BUY	$1.03 - $1.8 $2,552 - $4,460	2,478 Added 74.19%	5,818 $6,000
Q4 2022 Feb 09, 2023	BUY	$1.7 - $30.2 $5,678 - $100,868	3,340 New	3,340 $5,000
Q2 2022 Aug 11, 2022	BUY	$1.6 - $3.07 $160 - $307	100 New	100 $0

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $33.8M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.